Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy

Firdessa-Fite, R., Johnson, S. N., Bechi Genzano, C., Leon, M. A., Ku, A., Ocampo Gonzalez, F. A., Milner, J. D., Sestak, J. O., Berkland, C., & Creusot, R. J. (2024). Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1258369
Authors:
Rebuma Firdessa-Fite
Stephanie N Johnson
Camillo Bechi Genzano
Martin A Leon
Amy Ku
Fernando A Ocampo Gonzalez
Joshua D Milner
Joshua O Sestak
Cory Berkland
Remi J Creusot
Affiliated Authors:
Rebuma Firdessa-Fite
Camillo Bechi Genzano
Amy Ku
Fernando A Ocampo Gonzalez
Joshua D Milner
Remi J Creusot
Columbia Affiliation:
Subjects:
Genetics and Pathogenesis of Type 1 Diabetes (OpenAlex Topic)
Natural Killer Cells in Immunity (OpenAlex Topic)
Regulatory T Cell Development and Function (OpenAlex Topic)
Mice, Inbred NOD (MeSH)
Diabetes Mellitus, Type 1 (MeSH)
Immune Tolerance (MeSH)
Peptides (MeSH)
Author Keywords:
soluble antigen array
peptide modification
peptide delivery
immunotherapy
autoimmune diabetes
anaphylaxis
elink
Publication Type:
Article
Unique ID:
10.3389/fimmu.2024.1258369
PMID:
38933266
DOI:
10.3389/fimmu.2024.1258369
Journal:
Frontiers in Immunology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record
View Web of Science Record

Record Created: